title: Immunization with hybrid proteins containing the membrane proximal external region of HIV-1.
abstract: The transmembrane envelope (TM) protein gp41 of HIV-1 is an attractive target when designing a vaccine to induce neutralizing antibodies. A few broadly neutralizing antibodies (2F5, 4E10, and 10E8) that target conserved epitopes in the membrane proximal external region (MPER) of gp41 have been isolated from infected individuals. However, attempts to induce such antibodies by immunizations with gp41 and Env derivatives containing the MPER were successful only to some extent. In contrast, immunizations with the ectodomain of the TM protein p15E of different gamma retroviruses resulted in the induction of neutralizing antibodies. These sera recognized epitopes located in the MPER and in the fusion peptide proximal region (FPPR) of p15E. Based on these results, both regions of p15E were substituted with the corresponding sequences derived from gp41 of HIV-1. Thus, four different hybrid antigens were produced. One of the inserted sequences contained the epitopes of 2F5 and 4E10 in the MPER; the other corresponded to the FPPR. Vaccination of rats, guinea pigs, and a goat induced binding antibodies directed against the FPPR of gp41 and the 2F5 epitope (ELDKWA) located in the MPER. Despite the exact recognition of the 2F5 epitope, no or very weak neutralization of HIV-1NL4-3 by the immune sera was demonstrated. Nonetheless, using the strategy of hybrid proteins, antibodies targeting the desired epitope were successfully induced.
authors.affiliation: Robert Koch-Institute , Berlin, Germany .
authors.forename: Nicola
authors.initials: N
authors.lastname: Strasz
authors.forename: Vladimir A
authors.initials: VA
authors.lastname: Morozov
authors.forename: Jürgen
authors.initials: J
authors.lastname: Kreutzberger
authors.forename: Martina
authors.initials: M
authors.lastname: Keller
authors.forename: Magdalena
authors.initials: M
authors.lastname: Eschricht
authors.forename: Joachim
authors.initials: J
authors.lastname: Denner
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage / Q000276:immunology*; D000818:Animals; D057134:Antibodies, Neutralizing / Q000097:blood; D006041:Goats; D006168:Guinea Pigs; D015483:HIV Antibodies / Q000097:blood; D015700:HIV Envelope Protein gp41 / Q000235:genetics / Q000276:immunology*; D009500:Neutralization Tests; D017208:Rats, Wistar; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology
chemical_list: D016915:AIDS Vaccines; D057134:Antibodies, Neutralizing; D015483:HIV Antibodies; D015700:HIV Envelope Protein gp41; D011993:Recombinant Fusion Proteins; D014614:Vaccines, Synthetic; C514787:gp41 protein, Human immunodeficiency virus 1